ASHLEY HOLLAND: Open Payments
NPI 1649413774 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 49 payments from 16 companies in 2025. Trend: 2023 $1,623 · 2024 $1,259 · 2025 $1,603
Food & beverage: $1,603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $436 |
| Lilly USA, LLC | 6 | $228 |
| Enterra Medical, Inc. | 1 | $141 |
| Madrigal Pharmaceuticals | 2 | $139 |
| Janssen Biotech, Inc. | 1 | $135 |
| GENZYME CORPORATION | 4 | $115 |
| Gilead Sciences, Inc. | 1 | $113 |
| Novo Nordisk Inc | 1 | $82 |
| Abbott Laboratories | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: OMVOH, RINVOQ, REZDIFFRA, DUPIXENT, TREMFYA, Livdelzi, SKYRIZI, Wegovy.
Industry payments across GA — which companies pay providers there.
